-
Mashup Score: 1
Treatment and follow-up (FU) care procedures for gastrointestinal stromal tumors (GISTs) impose great challenges on patients and could potentially affect their health-related quality of life (HRQoL). The aims of our study were to (i) assess HRQoL among patients with GIST in different treatment phases and settings and to compare this with the HRQoL of an age- and sex-matched normative population, (ii) determine the occurrence of disease- and treatment-specific symptoms, and (iii) investigate which sociodemographic and clinical characteristics and symptoms were associated with HRQoL.
Source: www.esmorwd.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Patients with metastatic colorectal cancer (mCRC) with RAS- or BRAF-mutant tumors do not benefit from epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) therapy. Among patients with RAS/BRAF wild-type (WT) tumors, a substantial portion still do not benefit from EGFR mAb treatment. Using real-world clinicogenomic data, we investigated the impact of primary and acquired genomic resistance alterations upon treatment outcomes and determined the prevalence of alterations before and after EGFR mAb treatment.
Source: www.esmorwd.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Elsevier’s Oncology Journal Network Highlights | Elsevier - 20 day(s) ago
Welcome to our Elsevier’s Oncology Journal Network Highlights page
Source: www.elsevier.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Evaluation of machine learning methods for the retrospective detection of ovarian cancer recurrences from chemotherapy data - 20 day(s) ago
Cancer recurrences are poorly recorded within electronic health records around the world. This hinders research into the efficacy of cancer treatments. Currently, the retrospective identification of recurrence/progression diagnosis dates is achieved by staff who manually review patients’ health records. This is expensive, time-consuming, and inefficient. Machine Learning models may expedite the review of health records and facilitate the assessment of alternative cancer therapies.
Source: www.esmorwd.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0ADCs in HER2+ metastatic breast cancer brain metastases - 26 day(s) ago
Listen to this episode from ESMO Podcasts on Spotify. ESMO Open Editor-in-Chief Giuseppe Curgliano introduces a discussion between Dr Sara Hurwitz, of the Fred Hutcinson Cancer Center, Seattle, USA, and Dr Nancy Lin, of the Dana-Farber Cancer Institute, Boston USA, with ESMO Open Associate Editor Dr Paolo Tarantino, on the occasion of the publication of their articles on antibody-drug conjugate activity in patients with HER2-positive breast cancer brain metastases. See: Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial: https://www.esmoopen.com/article/S2059-7029(24)00692-6/fulltext and Antibody-drug conjugates are active in patients with HER2-positive breast cancer brain metastases: Where do we go from here?: https://www.esmoopen.com/article/S2059-7029(24)00758-0/fulltext
Source: open.spotify.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Impact of artificial intelligence in transforming the doctor–cancer patient relationship - 27 day(s) ago
The integration of Artificial Intelligence (AI) in oncology is a developing field, impacting the doctor-patient relationship and the efficacy of cance…
Source: www.sciencedirect.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
The PCAR study aimed to assess the efficacy and safety of preoperative transcatheter rectal arterial chemoembolisation (TRACE) in patients with locally advanced rectal cancer (LARC).
Source: www.clinicaloncologyonline.netCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Neuroblastoma (Year of the Zebra 2024) - 29 day(s) ago
What is neuroblastoma? Neuroblastoma is a childhood cancer that develops when neural crest cells do not mature properly and continue to proliferate in an imm…
Source: www.youtube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Adoption of electronic patient-reported outcomes in cancer clinical practice: the point of view of Italian patients - 29 day(s) ago
In 2022, the European Society for Medical Oncology (ESMO) guideline recommended the adoption of electronic patient-reported outcomes measures (ePROMs)…
Source: www.sciencedirect.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Elsevier’s Oncology Journal Network Highlights | Elsevier - 29 day(s) ago
Welcome to our Elsevier’s Oncology Journal Network Highlights page
Source: www.elsevier.comCategories: General Medicine News, Onc News and JournalsTweet
👩⚕️ How is health-related quality of life impacted by therapy in #GIST? #HRQoL Check out @myESMO ESMO Real World Data and Digital Oncology study: https://t.co/KJfdR83T6J 1/2